Trials / Completed
CompletedNCT02386852
Ginseng and Ginkgo Biloba Effects on Cognition as Modulated by Cardiovascular Reactivity
- Status
- Completed
- Phase
- EARLY_Phase 1
- Study type
- Interventional
- Enrollment
- 48 (actual)
- Sponsor
- Sunway University · Academic / Other
- Sex
- All
- Age
- 18 Years – 30 Years
- Healthy volunteers
- Accepted
Summary
There is some evidence to suggest that ginseng and Ginkgo biloba can improve cognitive performance, however, very little is known about the mechanisms associated with such improvement. Here, we tested whether cardiovascular reactivity to a task is associated with cognitive improvement.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Placebo | Study subjects received, in a double blind fashion, placebo pills identical to the drug (drug 1-ginseng, group 1; drug 2-ginkgo biloba-group 2) |
| DRUG | Ginseng | The ginseng group received two capsules containing either 1000 mg or 500 mg of Panax Ginseng extract standardized to 3% of ginsenosides (GNC, USA) or similarly looking placebo capsules over a period of three days of testing. |
| DRUG | Ginkgo Biloba | The ginkgo group received two capsules containing either 240 mg or 120 mg of ginkgo biloba extract standardized to 24% ginkgo flavone glycosides and 6% terpene lactones (GBE24/6) or similarly looking placebo capsules over a period of three testing days. |
Timeline
- Start date
- 2014-03-01
- Primary completion
- 2014-11-01
- Completion
- 2014-11-01
- First posted
- 2015-03-12
- Last updated
- 2015-03-13
Locations
1 site across 1 country: Malaysia
Source: ClinicalTrials.gov record NCT02386852. Inclusion in this directory is not an endorsement.